ACOG issues perimenopause management toolkit
Obstetrics & Gynecology published the American College of Obstetricians and Gynecologists document with no FDA-approved therapies specific to this stage.
23 September 2026 · Medscape
Clinic
Menopause
50 clippings on the rack, newest printed 23 September 2026.
Earlier cuttings
Oral menopausal hormones tied to extra clots in Danish records
Absolute rises with oral estrogen were 0.09% VTE, 0.06% ischemic stroke and 0.03% heart attack per year.
23 Sept · Medical Xpress
ERβ-only drug shifts metabolism in ovariectomized rats
An experimental compound that activates only estrogen receptor beta was tested after ovaries were removed to simulate menopause.
23 Sept · Agência FAPESP
HRT window and duration linked to lower LATE-NC odds
In 2,056 adults 65 and older from the Rush Religious Orders Study and Memory and Aging Project, 8–16 years of HRT had an aOR of 0.44 versus none.
22 Sept · Neurology Advisor
Hormone therapy linked to fewer menopause mood symptoms
In 260 women, the share with mood symptoms fell from 62% before federally approved hormone therapy to nearly 25% after.
15 Sept · Daily Jang
Ireland weighs public funding for fezolinetant
The HSE has received a commercial pricing proposal for Veoza; reimbursement is not decided.
15 Sept · Irish Medical Times
Earlier menopause tied to faster late-life cognitive drop
Earlier menopause was associated with faster late-life cognitive aging, including global decline and episodic memory.
15 Sept · Practical Neurology
FDA now says women cannot get estrogen patches
Agency is working with six manufacturers after almost a year of saying there was no shortage.
10 Sept · USA TODAY
Ohio State gets $3 million to study menopause in veterans
The four-year U.S. Department of Defense project will enroll 125 veterans ages 45 to 55.
10 Sept · Yahoo
Study suggests hormone therapy may ease midlife mood
Results went online in Menopause on Sept. 9, 2026.
9 Sept · The Menopause Society
Earlier menopause tied to faster memory loss later
Among 2,603 older women followed for up to 18 years, menopause 10 years earlier tracked with about 1.8 fewer Alzheimer's-free years at the average age of diagnosis.
9 Sept · Medical Xpress
Manulife HRT claims jump among midlife women
The insurer reports a 228 per cent rise in hormone replacement therapy claims over five years for Canadian women aged 45 to 54.
8 Sept · WestCentralOnline.com
Menopause rarely lands in the medical record
In nearly 396,000 women in NIH All of Us, electronic records captured menopause for only about 7%.
8 Sept · News-Medical
.png)
Menopause far more common in surveys than in records
In nearly 396,000 women in the NIH All of Us Research Program, menopause was in EHRs for only about 7%.
8 Sept · University of Colorado Anschutz
Menopause poorly captured in health records
A systematic review of 19 studies from 2013 to 2026 found inconsistencies in every dataset examined.
4 Sept · Healio
HRT claims climb fastest at 45 to 54
Manulife Canada's Group Benefits recorded a 228 per cent five-year rise in Hormone Replacement Therapy claims among women in that age band.
2 Sept · Yahoo Finance / CNW Group
Earlier menopause tied to faster later cognitive decline
In 2,603 older women, each year earlier multiplied time to Alzheimer’s diagnosis by 0.998.
2 Sept · Medscape
Menopause still missing from structured health records
A scoping review in Menopause finds status and symptoms often inferred from proxies rather than staged.
2 Sept · medicalxpress.com
Menopause status often inferred, not staged, in EHRs
A scoping review published in Menopause, the journal of The Menopause Society, finds menopause data in electronic health records are frequently incomplete, inconsistently coded, or left in unstructured notes.
2 Sept · The Menopause Society
Few women link dry eye to menopause
Only 14% of peri-, menopausal and post-menopausal women in a Bausch + Lomb survey recognized dry eye as menopause-related.
1 Sept · Yahoo Finance / Business Wire
Age, not menopause, tracks the TSH climb
A 2004–2024 Tokyo checkup cohort of 7644 healthy women with natural menopause found no abrupt TSH shift at the transition.
1 Sept · Medscape
HRT tied to modestly lower dementia risk in UK data
Women who used HRT had a 10% lower risk of developing dementia than peers who did not, in an analysis of more than 180,000 postmenopausal women.
29 Aug · Business Insider
Hormone therapy users about 10% less likely to get dementia
Researchers followed more than 180,000 postmenopausal UK Biobank participants for an average of 13 years; nearly 4,000 developed dementia.
28 Aug · usnews.com
Most women are still confused about menopause symptoms and treatments
A July ThisIsMenopause survey of 1,000 women ages 35-59 found 82% attributed early perimenopause signs to something else such as anxiety or everyday stress.
28 Aug · emarketer.com
Reddit menopause talk outruns clinic notes
Women discussed emotional well-being nearly three times as often online as it appeared in more than 2 million University of California, San Francisco electronic health record notes.
27 Aug · statnews.com
HRT linked to lower dementia risk in UK Biobank
Over 13 years, HRT use of at least one year was associated with all-cause dementia HR 0.90 (95% CI 0.84-0.96) among 183,450 postmenopausal women.
27 Aug · medpagetoday.com
UCLA opens a West Coast menopause clinic
On Aug. 26, 2026, UCLA Health said Rajita Patil, Brittany Davis, and Erica Oberman launched the only comprehensive menopause program of its kind on the West Coast.
26 Aug · uclahealth.org
HRT use linked to lower dementia rates in UK Biobank women
Researchers followed 183,450 postmenopausal women for an average of 13.3 years and identified almost 4,000 dementia cases.
26 Aug · EurekAlert
Hormone therapy tied to fewer Alzheimer’s diagnoses
On Aug. 26, 2026, a U.K. Biobank analysis of 183,450 postmenopausal women found an 11% lower Alzheimer’s risk with hormone therapy after natural menopause.
26 Aug · nytimes.com
HRT linked to lower dementia risk in 13-year UK Biobank follow-up
Scientists tracked 183,450 postmenopausal women in UK Biobank for an average of 13 years and identified almost 4,000 dementia cases.
26 Aug · theguardian.com
Night sweats alone track with sleep trouble and low energy
In 841 women ages 40–60, night sweats without hot flashes nearly doubled reported trouble sleeping versus neither symptom.
21 Aug · Yahoo
Fezolinetant VigiAccess scan flags liver and nerve reports
1,091 individual case safety reports and 2,143 adverse events were pulled from WHO VigiAccess, most from 2024.
18 Aug · journals.lww.com
Mayo Clinic recruits tirzepatide for hot flashes in obesity
NCT07218445 last updated 2026-08-18 is recruiting 40 postmenopausal women ages 46-60 with obesity and bothersome hot flashes for 24 weeks of tirzepatide versus placebo.
18 Aug · clinicaltrials.gov
Later estrogen-only therapy associated with lower dementia odds
Among 21,462 women, users had 39% lower odds of a clinical dementia diagnosis.
14 Aug · ScienceDaily
Estrogen-only MHT tied to less Alzheimer’s pathology
Autopsies from 258 women who reported estrogen-only menopausal hormone therapy were compared with roughly 2,701 never users drawn from databases of more than 21,000 women.
14 Aug · nypost.com
Hormone therapy use nearly doubles, still uncommon
Epic’s outpatient dataset covering more than 163 million American women showed use rising from 1.7 percent in January 2017 to about 3.6 percent in April 2026.
14 Aug · womenshealthmag.com
Unemployment strongest social link to death and dementia after early menopause
Among nearly 20,000 women with early natural menopause, unemployment had the strongest association of social-disadvantage variables with all-cause mortality and incident dementia.
12 Aug · The Menopause Society
ABCL-635 cuts hot flashes 83% at four weeks
Placebo-adjusted drop was 5.3 moderate-to-severe events a day among 92 post-menopausal patients in Phase II.
10 Aug · Yahoo Finance
Diabetes linked to worse postmenopausal symptoms
Researchers at Eulji University and Asan Medical Center in Seoul surveyed 296 South Korean females ages 45 to 64.
10 Aug · healthline.com
Hormone therapy demand spikes after years of caution
Prescriptions for menopausal hormone therapy fell from an estimated 22% of American women over 40 in 1999-2000 to around 5% by 2010 after the Women's Health Initiative.
7 Aug · npr.org
Type 2 diabetes linked to heavier menopause symptoms
A study of nearly 300 women aged 40 to 64 found a suggested association of type 2 diabetes with more, and more severe, menopause symptoms.
4 Aug · The Menopause Society
Louisville clinic walks through the new HRT rules
On Aug. 3, 2026, Norton Women’s Care published Anna Feitelson’s read of updated FDA communications and the shift away from WHI-era fear.
3 Aug · nortonhealthcare.com
Perimenopause pipeline: NK3 drugs, E4, cendifensine
On July 31, 2026, Medscape dated Sarah Amandalore’s report: cendifensine cut moderate-to-severe hot-flash frequency 92% at 12 weeks in phase 2.
31 Jul · medscape.com
WHI and HABITS data still shape reluctance for survivors
The HABITS trial ended early in 2003 after 26 of 219 women on menopausal hormone therapy developed breast cancer versus 8 of 215 who did not.
30 Jul · theconversation.com
Fezolinetant and elinzanetant now frame nonhormonal care
Fezolinetant (Veozah; Astellas Pharma US, Inc) became the first FDA-approved NK3 receptor antagonist for moderate-to-severe VMS.
30 Jul · pharmacytimes.com
Health Canada authorized Lynkuet for menopausal VMS
Lynkuet 60 mg capsules were authorized after a New Drug Submission by Bayer Inc. for moderate to severe vasomotor symptoms associated with menopause.
Drug and Health Products Portal
UCLA program treats hot flashes as a vascular warning
75% of people experience hot flashes during menopause, fewer than 50% get treatment.
uclahealth.org
GS1-144 cuts hot-flash frequency in Chinese phase 2
Among 276 randomized women, 30 mg twice daily reduced moderate-to-severe VMS by 1.41 episodes a day versus placebo at week 12.
journals.lww.com
Pfizer page puts U.S. menopause incidence at 1.3 million a year
An estimated 1.3 million people assigned female at birth reach menopause annually in the U.S.
pfizer.com
Oura adds Menopause Insights
The feature uses a Menopause Impact Scale questionnaire covering 22 symptoms.
Digital Health News
Five clippings on Menopause every morning, and you're done. iPhone.